U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine

U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine
U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine Copyright Thomson Reuters 2021
By Reuters
Share this articleComments
Share this articleClose Button

- A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.

Share this articleComments

You might also like

"Nonsense": Putin rules out attacks on NATO countries

Middle East Forum Israel: 'Gutteres wants Israel to lose, but he will fail'

'Disturbing': Rough sleepers and migrants removed from Paris ahead of Olympics